165 related articles for article (PubMed ID: 17496547)
1. Rituximab therapy for acute humoral rejection after kidney transplantation.
Faguer S; Kamar N; Guilbeaud-Frugier C; Fort M; Modesto A; Mari A; Ribes D; Cointault O; Lavayssière L; Guitard J; Durand D; Rostaing L
Transplantation; 2007 May; 83(9):1277-80. PubMed ID: 17496547
[TBL] [Abstract][Full Text] [Related]
2. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
[TBL] [Abstract][Full Text] [Related]
3. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation.
Pascual M; Saidman S; Tolkoff-Rubin N; Williams WW; Mauiyyedi S; Duan JM; Farrell ML; Colvin RB; Cosimi AB; Delmonico FL
Transplantation; 1998 Dec; 66(11):1460-4. PubMed ID: 9869086
[TBL] [Abstract][Full Text] [Related]
4. [Induction treatment by combining immunoglobulins, plasmapheresis and rituximab in hypersensitive patients receiving cadaveric renal allograft].
Rufino Hernández JM; Cabello Moya E; González-Posada JM; Hernández Marrero D; Pérez Tamajón L; Marrero Miranda D; García Rebollo S; Martín Urcuyo B; Rodríguez Hernández A; Franco Maside A; Barrios del Pino Y; Rodríguez Rodríguez R; Maceira Cruz B; Torres Ramírez A; Salido Ruiz E
Nefrologia; 2010; 30(2):252-7. PubMed ID: 20098463
[TBL] [Abstract][Full Text] [Related]
5. Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study.
Loupy A; Suberbielle-Boissel C; Zuber J; Anglicheau D; Timsit MO; Martinez F; Thervet E; Bruneval P; Charron D; Hill GS; Nochy D; Legendre C
Transplantation; 2010 Jun; 89(11):1403-10. PubMed ID: 20386362
[TBL] [Abstract][Full Text] [Related]
6. C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil.
Liu M; Ji SM; Tang Zh; Ji DX; Chen HP; Liu ZH; Li LS
Transplant Proc; 2004 Sep; 36(7):2101-3. PubMed ID: 15518760
[TBL] [Abstract][Full Text] [Related]
7. A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation.
Tydén G; Genberg H; Tollemar J; Ekberg H; Persson NH; Tufveson G; Wadström J; Gäbel M; Mjörnstedt L
Transplantation; 2009 May; 87(9):1325-9. PubMed ID: 19424032
[TBL] [Abstract][Full Text] [Related]
8. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil.
Sun Q; Liu ZH; Cheng Z; Chen J; Ji S; Zeng C; Li LS
Kidney Int; 2007 Jan; 71(1):24-30. PubMed ID: 16969384
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.
Kamburova EG; Koenen HJ; van den Hoogen MW; Baas MC; Joosten I; Hilbrands LB
PLoS One; 2014; 9(11):e112658. PubMed ID: 25393622
[TBL] [Abstract][Full Text] [Related]
10. Late acute antibody mediated rejection after nine years of renal transplantation.
Halim MA; Al-Otaibi T; Al-Waheeb S; Tawab KA; El Kholy O; Nair P; Said T; Narayanan Nampoory MR
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1111-4. PubMed ID: 21060182
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in highly sensitized kidney transplant recipients.
Munoz AS; Rioveros AA; Cabanayan-Casasola CB; Danguilan RA; Ona ET
Transplant Proc; 2008 Sep; 40(7):2218-21. PubMed ID: 18790197
[TBL] [Abstract][Full Text] [Related]
12. Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment.
Ishida H; Furusawa M; Shimizu T; Nozaki T; Tanabe K
Transpl Int; 2014 Apr; 27(4):371-82. PubMed ID: 24438437
[TBL] [Abstract][Full Text] [Related]
13. Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report.
Celik A; Saglam F; Cavdar C; Sifil A; Atila K; Sarioglu S; Bora S; Gulay H; Camsari T
Transplant Proc; 2008; 40(1):302-4. PubMed ID: 18261611
[TBL] [Abstract][Full Text] [Related]
14. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab.
Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K
Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409
[TBL] [Abstract][Full Text] [Related]
15. Novel rescue therapy for C4d-positive acute humoral renal allograft rejection.
Min L; Shuming J; Zheng T; Daxi J; Huiping C; Zhihong L; Leishi L
Clin Transplant; 2005 Feb; 19(1):51-5. PubMed ID: 15659134
[TBL] [Abstract][Full Text] [Related]
16. New treatments for acute humoral rejection of kidney allografts.
Venetz JP; Pascual M
Expert Opin Investig Drugs; 2007 May; 16(5):625-33. PubMed ID: 17461736
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
Han S; Hwang E; Park S; Park U; Kim H; Cho W
Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
[TBL] [Abstract][Full Text] [Related]
18. Rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil for C4d-positive acute humoral renal allograft rejection.
Ji SM; Liu ZH; Chen JS; Sha GZ; Ji DX; Li LS
Transplant Proc; 2006 Dec; 38(10):3459-63. PubMed ID: 17175303
[TBL] [Abstract][Full Text] [Related]
19. Development of antibody mediated rejection shortly after acute cellular rejection in a pediatric kidney transplantation recipient.
Okada M; Kamei K; Matsuoka K; Ito S
CEN Case Rep; 2018 Nov; 7(2):288-291. PubMed ID: 29949115
[TBL] [Abstract][Full Text] [Related]
20. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
Sarwal MM; Vidhun JR; Alexander SR; Satterwhite T; Millan M; Salvatierra O
Transplantation; 2003 Nov; 76(9):1331-9. PubMed ID: 14627912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
